On the other hand, chronic ANP treatment ameliorates hypertension and end-organ damage in the kidney by reducing oxidative stress, increasing NO system activity, and diminishing collagen content and apoptosis in the SHR animal model [75]. This evidence concerns the gene NPPA and Hypertension.